OSTX
What one share of Os Therapies Incorporated holds
Pharmaceutical Preparations
(“OS Therapies,” the “Company,” “we,” “our” or “us”) is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors.
Os Therapies Incorporated’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$1.05 |
|---|---|
| Cash and investments | $0.00 |
| Book value | −$0.26 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2023 | — | −$1.46 | — | −$0.55 | — | −$4.50 |
| 2024 | — | −$1.28 | — | −$1.05 | — | — |
| 2025 | — | −$0.98 | $0.02 | −$0.50 | — | −$0.16 |